NSUP
GILD icon

NLB Skladi upravljanje premozenja’s Gilead Sciences GILD Stock Holding History

NLB Skladi upravljanje premozenja’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.61M Sell
28,587
-898
-3% -$118K 0.14% 124
2026
Q1 		$4.11M Sell
29,485
-44,321
-60% -$6.21M 0.2% 113
2025
Q4 		$9.06M Buy
+73,806
New +$8.97M 0.41% 59

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

NLB Skladi upravljanje premozenja's GILD Position: Q2 2026 in Review

NLB Skladi upravljanje premozenja reduced its Gilead Sciences (GILD) stake by 3% in Q2 2026, selling an estimated $118K and leaving 28,587 shares worth $3.61M. The position accounts for 0.14% of the portfolio, ranked #124.

NLB Skladi upravljanje premozenja first reported a position in GILD in Q4 2025 and has held it in 3 quarters since. The position peaked at $9.06M in Q4 2025. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • NLB Skladi upravljanje premozenja held 28,587 shares of Gilead Sciences worth $3.61M as of Q2 2026.
  • NLB Skladi upravljanje premozenja sold 898 Gilead Sciences shares in Q2 2026, an estimated $118K.
  • Gilead Sciences made up 0.14% of NLB Skladi upravljanje premozenja's portfolio in Q2 2026, its #124 holding.
  • NLB Skladi upravljanje premozenja first reported a position in Gilead Sciences in Q4 2025 and has held it in 3 quarters since.
  • NLB Skladi upravljanje premozenja's Gilead Sciences position peaked at $9.06M in Q4 2025.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on NLB Skladi upravljanje premozenja's 13F filing for Q2 2026, filed 6 Aug 2026.